Improvement of hematological and general tolerance to CMF by high-dose medroxyprogesterone acetate (HD-MPA) adjuvant treatment for primary node positive breast cancer (analysis of 100 patients) (Q70021022)
Jump to navigation
Jump to search
scientific article published on 01 September 1986
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improvement of hematological and general tolerance to CMF by high-dose medroxyprogesterone acetate (HD-MPA) adjuvant treatment for primary node positive breast cancer (analysis of 100 patients) |
scientific article published on 01 September 1986 |
Statements
Improvement of hematological and general tolerance to CMF by high-dose medroxyprogesterone acetate (HD-MPA) adjuvant treatment for primary node positive breast cancer (analysis of 100 patients) (English)
Focan C
Baudoux A
Beauduin M
Bunescu U
Dehasque N
Dewasch L
Lobelle JP
Longeval E
Majois F
1 September 1986